Form 8-K - Current report:
SEC Accession No. 0001193125-23-158979
Filing Date
2023-06-01
Accepted
2023-06-01 16:30:54
Documents
13
Period of Report
2023-06-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d463989d8k.htm   iXBRL 8-K 25139
2 EX-99.1 d463989dex991.htm EX-99.1 17719
  Complete submission text file 0001193125-23-158979.txt   173874

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230601.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230601_lab.xml EX-101.LAB 18756
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230601_pre.xml EX-101.PRE 11723
7 EXTRACTED XBRL INSTANCE DOCUMENT d463989d8k_htm.xml XML 3526
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 23985169
SIC: 2834 Pharmaceutical Preparations